NCT00003974
- Conditions
- Adenoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +16 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
Clinical trial condition
Mesothelioma, Malignant
Explore clinical trials studying Mesothelioma, Malignant. Study availability and eligibility vary by location and protocol.
225 public trials
44 recruiting studies
Mesothelioma, Malignant trial results
NCT00054002
- Conditions
- Adenoma, Lung Diseases, Lung Neoplasms, +17 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
NCT01243632
- Conditions
- Adenoma, Lung Diseases, Lung Neoplasms, +12 more
- Locations
-
- Institute of Oncology Ljubljana Ljubljana, Slovenia
NCT00280982
- Conditions
- Adenoma, Lung Diseases, Lung Neoplasms, +12 more
- Locations
-
- Department of Pulmonary Medicine Rotterdam, South Holland, Netherlands
NCT00272558
- Conditions
- Adenoma, Lung Diseases, Lung Neoplasms, +12 more
- Locations
-
- Dept. Oncol., Rigshospitalet Copenhagen, Denmark
NCT00386815
- Conditions
- Adenoma, Lung Diseases, Lung Neoplasms, +12 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hokkaido, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyōgo, Japan
Active, Not Recruiting
MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma
NCT06097728
- Conditions
- Adenoma, Lung Diseases, Lung Neoplasms, +12 more
- Locations
-
- Research Site Santa Rosa, California, United States
- Research Site Aurora, Colorado, United States
- Research Site Jacksonville, Florida, United States
- Research Site Atlanta, Georgia, United States
Active, Not Recruiting
Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma
NCT01843374
- Conditions
- Adenoma, Diabetes Mellitus, Insulin-Dependent, 12, Lung Diseases, +13 more
- Locations
-
- Research Site Scottsdale, Arizona, United States
- Research Site La Jolla, California, United States
- Research Site Los Angeles, California, United States
- Research Site San Francisco, California, United States
Active, Not Recruiting
Mesothelin-targeted CAR T-cell Therapy in Patients With Mesothelioma
NCT04577326
- Conditions
- Adenoma, Lung Diseases, Lung Neoplasms, +12 more
- Locations
-
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) New York, United States
Active, Not Recruiting
Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma
NCT03228537
- Conditions
- Adenoma, Biphasic Mesothelioma, Epithelioid Mesothelioma, +18 more
- Locations
-
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- CHI Saint Vincent Cancer Center Hot Springs Hot Springs, Arkansas, United States
- PCR Oncology Arroyo Grande, California, United States